Acrivon Therapeutics (ACRV) Institutional Ownership → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free ACRV Stock Alerts $8.77 +0.63 (+7.74%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Acrivon Therapeutics (NASDAQ:ACRV)CurrentInstitutional OwnershipPercentage71.62%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$529.85KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$781.28K Get ACRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACRV Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Acrivon Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024Vanguard Group Inc.507,185$3.63M0.0%+6.6%2.241% 1/5/2024 Exchange Traded Concepts LLC13,289$65K0.0%+34.0%0.060% 11/13/2023Federated Hermes Inc.226,375$2.16M0.0%-25.6%1.020% 9/21/2023Barclays PLC14,263$184K0.0%-16.0%0.065% 8/10/2023 AAF Wealth Management LLC10,678$138K0.1%N/A0.049% 7/20/2023 Exchange Traded Concepts LLC11,709$152K0.0%N/A0.053% 5/8/2023Federated Hermes Inc.613,625$7.79M0.0%-25.5%2.798% 2/16/2023HealthCor Management L.P.284,201$3.27M3.0%N/A1.360% 2/14/2023RA Capital Management L.P.4,810,508$55.42M1.1%N/A23.028% 2/13/2023Sands Capital Ventures LLC1,652,605$19.04M5.2%N/A7.913% 2/10/2023NEA Management Company LLC481,677$4.44M0.2%N/A2.306% 2/1/2023Bank of Montreal Can42,444$545K0.0%N/A0.203% (Data available from 1/1/2016 forward) ACRV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACRV shares? During the previous two years, 10 institutional investors and hedge funds held shares of Acrivon Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($55.42M), Sands Capital Ventures LLC ($19.04M), NEA Management Company LLC ($4.44M), Vanguard Group Inc. ($3.63M), HealthCor Management L.P. ($3.27M), Federated Hermes Inc. ($2.16M), and Bank of Montreal Can ($545K).Learn more on ACRV's institutional investors. What percentage of Acrivon Therapeutics stock is owned by institutional investors? 71.62% of Acrivon Therapeutics stock is owned by institutional investors. Learn more on ACRV's institutional investor holdings. Which institutional investors have been buying Acrivon Therapeutics stock? The following institutional investors have purchased Acrivon Therapeutics stock in the last 24 months: RA Capital Management L.P. ($4.81M), Sands Capital Ventures LLC ($1.65M), NEA Management Company LLC ($481.68K), HealthCor Management L.P. ($284.20K), Bank of Montreal Can ($42.44K), Vanguard Group Inc. ($31.21K), and Exchange Traded Concepts LLC ($15.08K). How much institutional buying is happening at Acrivon Therapeutics? Institutional investors have bought a total of 7,328,400 shares in the last 24 months. This purchase volume represents approximately $84.30M in transactions. Which Acrivon Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Acrivon Therapeutics stock in the last 24 months: Federated Hermes Inc. ($287.71K), and Barclays PLC ($2.72K). How much institutional selling is happening at Acrivon Therapeutics? Institutional investors have sold a total of 290,431 shares in the last 24 months. This volume of shares sold represents approximately $3.44M in transactions. Related Companies: Lifecore Biomedical Institutional Ownership Trevi Therapeutics Institutional Ownership Galectin Therapeutics Institutional Ownership Rigel Pharmaceuticals Institutional Ownership Omeros Institutional Ownership Generation Bio Institutional Ownership Ovid Therapeutics Institutional Ownership Alimera Sciences Institutional Ownership Atossa Therapeutics Institutional Ownership Organigram Institutional Ownership This page (NASDAQ:ACRV) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.